402 related articles for article (PubMed ID: 9713937)
21. Mucosal and systemic immune responses of mice to tetanus toxoid coadministered nasally with AFCo1.
Romeu B; González E; Del Campo J; Acevedo R; Zayas C; Valdés Y; Cabrera O; Cuello M; Balboa J; Lastre M; Pérez O
Can J Microbiol; 2011 Mar; 57(3):256-61. PubMed ID: 21358768
[TBL] [Abstract][Full Text] [Related]
22. A vaccination strategy incorporating DNA priming and mucosal boosting using tetanus toxin fragment C (TetC).
Stratford R; Douce G; Bowe F; Dougan G
Vaccine; 2001 Nov; 20(3-4):516-25. PubMed ID: 11672917
[TBL] [Abstract][Full Text] [Related]
23. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates.
Johansson EL; Rask C; Fredriksson M; Eriksson K; Czerkinsky C; Holmgren J
Infect Immun; 1998 Feb; 66(2):514-20. PubMed ID: 9453604
[TBL] [Abstract][Full Text] [Related]
24. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
25. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.
Blanchard TG; Lycke N; Czinn SJ; Nedrud JG
Immunology; 1998 May; 94(1):22-7. PubMed ID: 9708182
[TBL] [Abstract][Full Text] [Related]
26. Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract.
Gockel CM; Bao S; Beagley KW
Mol Immunol; 2000 Jun; 37(9):537-44. PubMed ID: 11163403
[TBL] [Abstract][Full Text] [Related]
27. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.
Medaglini D; Ciabattini A; Spinosa MR; Maggi T; Marcotte H; Oggioni MR; Pozzi G
Vaccine; 2001 Feb; 19(15-16):1931-9. PubMed ID: 11228363
[TBL] [Abstract][Full Text] [Related]
28. Sublingual immunization with an engineered Bacillus subtilis strain expressing tetanus toxin fragment C induces systemic and mucosal immune responses in piglets.
Amuguni H; Lee S; Kerstein K; Brown D; Belitsky B; Herrmann J; Keusch G; Sonenshein A; Tzipori S
Microbes Infect; 2012 May; 14(5):447-56. PubMed ID: 22198093
[TBL] [Abstract][Full Text] [Related]
29. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
[TBL] [Abstract][Full Text] [Related]
30. Oral vaccination against Helicobacter pylori with recombinant cholera toxin B-subunit.
Kubota E; Joh T; Tanida S; Sasaki M; Kataoka H; Watanabe K; Itoh K; Oshima T; Ogasawara N; Togawa S; Wada T; Yamada T; Mori Y; Fujita F; Shimura T; Ohara H; Isaka M; Yasuda Y; Itoh M
Helicobacter; 2005 Aug; 10(4):345-52. PubMed ID: 16104951
[TBL] [Abstract][Full Text] [Related]
31. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis.
Robinson K; Chamberlain LM; Schofield KM; Wells JM; Le Page RW
Nat Biotechnol; 1997 Jul; 15(7):653-7. PubMed ID: 9219268
[TBL] [Abstract][Full Text] [Related]
32. Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid.
Gupta RK; Siber GR
Biologicals; 1994 Mar; 22(1):53-63. PubMed ID: 8068314
[TBL] [Abstract][Full Text] [Related]
33. Antibody responses in serum and lung to intranasal immunization with Haemophilus influenzae type b polysaccharide conjugated to cholera toxin B subunit and tetanus toxoid.
Bergquist C; Lagergård T; Holmgren J
APMIS; 1998 Aug; 106(8):800-6. PubMed ID: 9744766
[TBL] [Abstract][Full Text] [Related]
34. Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant.
Goto N; Maeyama J; Yasuda Y; Isaka M; Matano K; Kozuka S; Taniguchi T; Miura Y; Ohkuma K; Tochikubo K
Vaccine; 2000 Apr; 18(20):2164-71. PubMed ID: 10715532
[TBL] [Abstract][Full Text] [Related]
35. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR
Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system.
Harokopakis E; Hajishengallis G; Michalek SM
Infect Immun; 1998 Sep; 66(9):4299-304. PubMed ID: 9712781
[TBL] [Abstract][Full Text] [Related]
37. Zonula occludens toxin acts as an adjuvant through different mucosal routes and induces protective immune responses.
Marinaro M; Fasano A; De Magistris MT
Infect Immun; 2003 Apr; 71(4):1897-902. PubMed ID: 12654806
[TBL] [Abstract][Full Text] [Related]
38. Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization.
Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
Infect Immun; 2001 Jan; 69(1):297-306. PubMed ID: 11119518
[TBL] [Abstract][Full Text] [Related]
39. Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses.
Okahashi N; Yamamoto M; Vancott JL; Chatfield SN; Roberts M; Bluethmann H; Hiroi T; Kiyono H; McGhee JR
Infect Immun; 1996 May; 64(5):1516-25. PubMed ID: 8613355
[TBL] [Abstract][Full Text] [Related]
40. IL-12 is an effective adjuvant for induction of mucosal immunity.
Boyaka PN; Marinaro M; Jackson RJ; Menon S; Kiyono H; Jirillo E; McGhee JR
J Immunol; 1999 Jan; 162(1):122-8. PubMed ID: 9886377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]